扁平苔蘚(lichen planus)聽起來是很普通的疾病,但在皮膚科卻是成因相當複雜,且難以治療的燙手山芋(剛好也是紫色的)。長在頭皮與指甲的病灶如果太晚治療,甚至會造成頭髮與指甲不可逆的消失。儘管扁平苔癬在臨床上相對少見,遇到的時候趕快診斷並給予正確治療才最重要的事。
Chapter 32 :: Lichen Planus Part 1
:: Aaron R. Mangold & Mark R. Pittelkow
鄭煜彬(20200329)
|
INTRODUCTION
|
|
|
What is the meaning of lichen planus(LP)?
|
Flat(planus) tree moss(lichen)
|
|
What is the involved tissue of LP?
|
Any ectodermal-derived tissue
|
|
What is the classification of LP?
|
Papulosquamous lesion (however, it just
has scant scales, not really “squamous”)
|
|
What is the four Ps of LP?
|
(1) purple, (2) polygonal, (3) pruritic,
& (4) papules
|
|
What is the histological feature of LP?
|
A brisk lymphocytic interface reaction
(lichenoid infiltration)
|
|
PATHOGENESIS
|
|
|
What contributing factors may cause LP?
|
Infectious, immune, metabolic, and
genetic causes
|
|
What is the main responder of LP?
|
Cell–mediated immunity(T cells). Immunoglobulins
(humoral immunity) is only secondary response.
|
|
What is the constitution of T cells in
LP? (Th or Tc?)
|
Dermis: CD4+ T-helper (CD4-Th)
Near basal keratinocytes: CD8+T-cytotoxic
(CD8-Tc)
|
|
What is the 4 stages of LP?
|
antigen recognition, lymphocyte
activation, keratinocyte apoptosis, resolution.
|
|
What is the pathogenesis of LP ?
|
Some antigen→Langerhans cell→↑MHC class II
receptors→↑CD4-Th (antigen recognition of HLA-DR(+) keratinocyte)→release
inflammatory cytokines (IFN-γ)→CD8-Tc oligoclonal expansion
|
|
What is the antigen of typical LP?
|
Unknown antigen
|
|
What is the antigen of lichenoid GVHD?
|
Alloantigens from the graft.
|
|
What is the antigen of oral LP?
|
MHC class I on keratinocytes (an
autoreactive peptide or an exogenous antigen?)
|
|
What are the exogenous antigen of LP?
|
1.
Inorganic mercury (dental
amalgam), gold (act as haptens)
2.
Syphilis, HSV 2, HIV,
amebiasis, chronic bladder infections, HCV, Helicobacter pylori, or HPV.
|
|
What are the cause of TNF- α associated lichenoid
tissue reactions(LTRs)?
|
TNF-α inhibitors (dysregulated cytokine) → upregulation of
type I IFN)
|
|
What is the major cytokine in LP?
|
IFN-γ (↑migration of lymphocytes to DEJ)
|
|
How does IFN-γ work in LP?
|
↑inflammatory
chemokines CXCL-9, 10, & 11→activate CXCR-3 on
CD4-Th
|
|
Why does peroxisome-proliferator-activated
receptor γ (PPARγ) stop scarring alopecia in LPP?
|
It inhibits CXCL-10 & 11
|
|
What is the mechanism of keratinocyte
apoptosis in LP?
|
CD8-Tc cells→granzyme B release,
TNF-α–TNF-α R1 receptor interaction, & Fas–Fas-L interaction
|
|
What is the mechanism of disruption of
the basement membrane in LP?
|
TNF-α→↑matrix metalloproteinase-9 (MMP-9), especially
in ulcerative lesions
|
|
What is the mechanism of the resolution
of LP?
|
1.
T-regulatory cells→↓Tc
2.
Fas-L, granzyme B, &
perforin on the keratinocytes: apoptosis of Tc
|
|
GENETIC AND EPIGENETIC REGULATION
|
|
|
What are the sites of gene polymorphisms
related to LP?
|
HLA,
immune signaling molecules & receptors (IFN-γ, TNF-α, TNF-α R2, IL-4,
IL-6, IL-18, NF-κB), PGE2, oxidative stress,
transglutaminase, thyroid hormone, & prothrombin.
|
|
What are miRNAs related to the epigenetic
regulation of LP?
|
micro-RNA (miRNA)-146a & -155
|
|
What are the most specific marker of LP?
|
CXCR-3 ligand & CXCL-9,
|
|
EPIDEMIOLOGY
|
|
|
How much is the prevalence of LP?
|
1% (0.1-4%), but not exact.
|
|
What is the age of most LP?
|
30-60 y/o (2/3 of all cases)
|
|
What is the peak onset of LP?
|
>55 y/o (elderly, earlier in women)
|
|
How much is the prevalence of childhood
LP?
|
1-5%, 20% in Pacific Indians. no sexual
predilection
|
|
What is the peak onset of childhood LP?
|
Between 8 & 12 years of age
|
|
What is the features of familial LP?
|
Family history(廢話), early onset, widespread & erosive/ulcerative disease,
mucosal involvement, & frequent relapses.
|
|
What is the HLA tendency in familial
& nonfamilial LP?
|
Familial: HLA-B27, Aw19, -B18, & -Cw8
Nonfamilial: HLA-A3, -A5, -A28, -B8,
-B16, & Bw35
|
|
What is the HLA tendency in oral & cutaneous
LP?
|
Oral: HLA-B8
Cutaneous: HLA-Bw35
|
|
CLINICAL FEATURES
|
|
|
Where is the locations of LP?
|
Skin, oral mucosa, any ectodermal-derived
tissue (hair, nails, internal & external genitalia, eyes, &
esophagus.)
|
|
How long is the development of typical
LP?
|
Over the course of weeks.
|
|
CUTANEOUS FINDINGS
|
|
|
What are the clinical featurs of LP?
|
1.
Well-marginated, dull
red-violet, flat-topped, polygonal papules. (4”Ps”)
2.
The grouped papules often
coalesce into plaques.
3.
Wickham striae, fine, white &
adherent reticulate scale (esp. in dermoscopy)
|
|
What is the meaning of Wickham striae?
|
1.
Characteristic features of LP
2.
Correlate with
orthokeratosis, epidermal thickening, & an ↑granular
layer.
|
|
Why does LP have dull red-violet hue?
|
Combination of vascular dilation &
pigment incontinence
|
|
Where are the typical locations of LP
lesions?
|
The flexural wrists, arms, legs, proximal
thighs, trunk, & neck, symmetrical distribution.
|
|
Where are the atypical locations of LP
lesions?
|
Face & palms
|
|
Where are the locations of inverse LP ?
|
Axillae, groin, & inframammary region
|
|
What is the most common symptom of LP?
|
Extreme pruritus (directly correlate with
the extent of involvement)
|
|
What type of LP affects limited areas but
has severe pruritus?
|
Hypertrophic LP (only lower extremities)
|
|
What is the name of trauma-induced
disease in acute LP?
|
Isomorphic (Koebner) phenomenon
|
|
What is the reason of isomorphic phenomenon?
|
Trauma→endogenous peptides (cathelicidin
LL-37) or antigens (DNA & RNA)→type I IFNs (-α
and -β) →LP
|
|
What is the common sequela of LP?
|
Postinflammatory hyperpigmentation, esp.
on darker skin. (hypopigmentation: other diagnosis)
|
|
What is the percentage of oral LP? (Adults
& children)
|
Adult: 42-60% (about 1/2)
Children: 17-30% (about 1/5)
|
|
What is the percentage of hair & nail
LP? (Adults & children)
|
Adult: 2-6% (about 1/20)
Children: 0-19% (about 1/10)
|
|
CLINICAL VARIANTS
|
|
|
How are LP variant categorized?
|
According to configuration, morphology,
& sites.
Configuration: annular LP, linear/ Blachkoid/
zosteriform LP
Morphologic appearance: hypertrophic LP,
atrophic LP
Site of involvements
|
|
What are the location of annular LP?
|
Penis & scrotum
|
|
What are the morphology of annular LP?
|
An arcuate grouping of individual papules→form a ring or
expand centrifugally with a central clearing & hyperpigmentation.
|
|
What is actinic LP
|
Annular LP in subtropical zones on
sun-exposed, dark-skinned young adults & children.
|
|
What is the cause of linear LP?
|
Trauma induces a row of LP papules.
|
|
What is the cause of Blaschkoid LP?
|
Postzygotic, somatic mutations in
susceptibility-associated genes
|
|
What is the cause of zosteriform LP?
|
A viral trigger of disease or an isotopic
response related to underlying resident memory cells.
|
|
What is the difference between linear
& zosteriform LP?
|
Linear LP does not follow dermatomal
lines.
Zosteriform LP follow dermatomal lines.
|
|
What are the differential diagnoses of
linear, Blaschkoid, zosteriform LP?
|
All segmental diseases: lichen striatus,
linear epidermal n., inflammatory linear & verrucal epidermal n., linear
psoriasis, & linear Darier dz.
|
|
Where are the locations of hypertrophic
LP?
|
Anterior shins & interphalangeal
joints.
|
|
What are the features of hypertrophic LP?
|
1.
Thickened, elevated,
purple-red, hyperkeratotic plaques & nodules, with follicular
accentuation & chalk-like scale.
2.
Highly pruritic, refractory
to treatment, & associated with relapse.
|
|
What are the differential diagnoses
verrucal lesions of hypertrophic LP?
|
Keratinocyte carcinomas, rupioid
psoriasis, rupioid syphilis, reactive arthropathy (Reiter's
syndrome), & cutaneous LE
|
|
What is the associated disease of
hypertrophic LP?
|
Chronic venous insufficiency
|
|
What are the features of atrophic LP?
|
Oligo-lesional, well-marginated,
blue-white papules or plaques with central atrophy.
|
|
Where are the locations of atrophic LP?
|
Proximal lower extremity & trunk
|
|
What are the differential diagnoses of
atrophic LP?
|
Lichen sclerosus et atrophicus &
mycosis fungoides
(MF)
|
|
What is the nature of atrophic LP?
|
Late-stage resolved disease of LP
|
|
What is the mechanism of vesiculobullous
LP?
|
Secondary to an exuberant inflammatory
response of LP (acute flares) & an exaggerated Max-Joseph space.
|
|
What are the features of LP pemphigoides?
|
1.
Classic LP + lesions of bullous
pemphigoid
2.
Bullous pemphigoid antibodies
(BP 180 and 230) & immunofluorescence.
|
|
What is the mechanism of LP pemphigoides?
|
LP→exposure of autoantigen→bullous pemphigoid antibody →BP lesions
|
|
Where are the locations of
vesiculobullous LP?
|
Lower extremities & oral cavity (became
erosion & ulcer).
|
|
What are the features of erosive &
ulcerative LP?
|
1.
Erosion & ulcer
2.
Significant pain &
scarring
3.
Other ectodermal involvement
(scarring alopecia & loss of the toenails)
4.
SCC in chronic lesions of
ulcerative oral LP.
|
|
Where are the locations of erosive &
ulcerative LP?
|
Feet & oral cavity
|
|
What are the 3 major variants of
follicular LP?
|
Lichen planopilaris (LPP), frontal
fibrosing alopecia(FFA), & Gram-Little-Piccardi-Lassueur syndrome (GLPLS)
|
|
What is the features of LP follicularis
tumidus (LPFT)?
|
Pruritic, red-violet pseudo-tumoral
facial & posterior auricular plaques + yellow cysts + LP elsewhere
|
|
What are the differential diagnoses of
LPFT?
|
Folliculotropic MF, & cutaneous lupus
erythematosus
|
|
What are the features of LP pigmentosus
(LPP)?
|
Hyperpigmented, dark-brown macules in
sun-exposed & flexural folds, usually in darker skinned individuals.
|
|
What is the relationship between LPP
& ashy dermatosis(erythema dyschromicum)?
|
A phenotypic spectrum based on genetic
&
environmental factors: they have
significant overlapping.
|
|
What are the features of actinic LP?
|
1.
Minimally symptomatic
2.
Annular, well-marginated,
hyperpigmented brown-violet, flat-topped, plaques with a slightly rolled
border
3.
Subtropical zones on
sun-exposed, dark-skinned young adults & children of Middle Eastern
descent
4.
In the spring & summer
months.
5.
Hx: a more brisk LTR relative to LP pigmentosus, vacuolar changes,
& pigment incontinence.
|
|
Where are the locations of actinic LP?
|
Face > the dorsal hands, arms, &
nape of the neck(sun-exposed skin)
|
|
Who predisposes LP of the scalp?
|
female
|
|
What are the 3 variants of LP of the scalp?
|
LPP, FFA, & GLPLS (the same as
follicular LP)
|
|
What are the features of classic LPP?
|
Individual perifollicular hyperkeratosis
+ diffuse livid erythema→plaques on the scalp→scarring alopecia
|
|
Where is the typical location of classic
LPP?
|
Vertex of the scalp
|
|
What are the features of LPP on the
dermoscope?
|
Absence of follicular opening, cicatricial
white patches, peripilar casts and perifollicular scale, blue-gray dots,
perifollicular erythema, & polytrichia (2 or 3 hairs)
|
|
What is the features of FFA?
|
1.
Progressive frontotemporal
recession (inflammatory)
2.
Loss of the eyebrows
(noninflammatory)
|
|
Who predisposes FFA?
|
Postmenopausal women (but can occur in
younger women)
|
|
What might be the cause of FFA?
|
Leave-on facial products, sun-screen,
& allergy to fragrances (positive patch test)
|
|
What are the features of GLPLS?
|
Cicatricial alopecia of the scalp,
nonscarring alopecia of the axilla & groin, & follicular papules on
the trunk & extremities.
|
|
What is the end stage of follicular LP?
|
Pseudopelade of Brocq (it can also be the
result of LE, pustular scarring forms of folliculitis, fungal infections,
scleroderma, & sarcoidosis.)
|
|
Where are the typical locations of
mucosal LP?
|
Mouth or genitalia
|
|
What are the types of oral LP?
|
Reticular(most common), plaque-like,
atrophic, papular, erosive or ulcerative, & bullous forms.
|
|
What are the locations & symptoms of
all the types of oral LP?
|
1.
Reticular: buccal >
tongue> gingiva (asymptomatic)
2.
Erosive & ulcerative:
tongue (extremely painful), gingiva (gingival stomatitis or desquamative
gingivitis)
|
|
What is the difference between oral LP
& oral lichenoid reactions (OLRs)
|
OLRs have an identifiable cause (They are
similar clinically & histologically)
|
|
Where is the common location or OLRs?
|
Buccal mucosa adjacent to amalgam dental
fillings
|
|
What is the result of patch test on the
patients with OLRs?
|
Positive reactions to mercury, gold,
& other metals→ negative after the removal of amalgams. (A special site irritant
reaction → koebnerization)
|
|
What are the features of oral LP on the
patients of HIV
|
1.
Bilateral reticular keratotic
or atrophic changes of the buccal mucosa
2.
Lichenoid atrophic patches
over the dorsal tongue
3.
Follows zidovudine or
ketoconazole intake (a unique drug hypersensitivity)
|
|
What is the features of esophageal LP?
|
1.
proximal esophagus (upper
1/3)
2.
middle-aged women
3.
preceding or concomitant oral
LP
4.
progressive dysphagia and
odynophagia
5.
lacy white papules, pinpoint
erosions, desquamation, pseudomembranes, & stenosis.
6.
Hx: parakeratosis (not in
skin LP), epithelial atrophy, & lack of hypergranulosis
|
|
What is the percentage of male genitalia
involvement of LP?
|
25% of all male cases
|
|
What is the most common pattern &
location of LP on male genitalia?
|
Annular lesions on glans penis
|
|
What are the features of anal LP?
|
Leukokeratosis, hyperkeratosis,
fissuring, & erosions
|
|
What are the features of vulvar &
vaginal LP?
|
1.
Combined with oral LP (in
25-60% oral LP cases)
2.
Patches of leukoplakia or
erythroplakia→erosive & atrophic disease→desquamative vaginitis
3.
Often asymptomatic→burning, itching,
painful erosion
|
|
What is vulvovaginal gingival syndrome
(VVGS)?
|
Triad of gingival/lingual erythema &
erosions, vulvar & vaginal desquamation & erosions. (Also involves skin/scalp/nails/esophagus
)
|
|
What are the significant long-term
sequelae of VVGS?
|
Fibrosis & stricture of vagina (needs
aggressive topical and systemic immunosuppression)
|
|
What are the HLA related to VVGS?
|
Class II HLA DBQ1∗0201 allele
|
|
What are the sequelae of conjunctival LP?
|
Cicatricial conjunctivitis.
|
|
What are the differential diagnoses of
conjunctival LP?
|
Paraneoplastic autoimmune multiorgan
syndrome
& paraneoplastic/cicatricial
pemphigoid
|
|
How to distinguish conjunctival LP with
other cicatricial conjunctivitis?
|
Direct immunofluorescence, indirect
immunofluorescence, & serologies for autoantibodies
|
|
What are the signs/symptoms of otic LP?
|
Otorrhea or external auditory canal
stenosis.
|
|
What is the long-term sequelae of otic
LP?
|
Progressive hearing loss(involvement of
external auditory canal & tympanic membrane)
|
|
What are the 3 major forms of nail LP?
|
Classic nail lichen planus , 20-nail
dystrophy, & idiopathic atrophy of the nails.
|
|
Which 2 forms of nail LP are common in
children?
|
20-nail dystrophy, & idiopathic
atrophy of the nails.
|
|
What are the common features of classic
nail LP?
|
Thinning, longitudinal ridging, distal
nail splitting (onychoschizia), onycholysis, longitudinal striation with a
“sandpaper-like quality” (onychorrhexis), subungual hyperkeratosis, &
atrophic or absent nail plates(anonychia)
|
|
What is the early finding of nail LP in
dermoscopy?
|
Nail pitting
|
|
What is the classic finding in nail LP involving
the matrix?
|
Pterygium or forward growth of the eponychia with adherence to the proximal
nail plate (irreversible, loss of nail plate)
|
|
What are the common features of 20-nail
dystrophy?
|
Trachyonychia (uniform roughness of the
20 nails), an indolent course.
|
|
What are the common features of idiopathic
atrophy of the nails?
|
Abrupt onset & rapidly progressive
thinning of the nails→subsequent loss & scarring ± dorsal pterygium
|
|
What are the differential diagnosis of
nail LP?
|
Psoriasis, alopecia areata, atopic
dermatitis, & rarely immunobullous diseases.
|
|
What are the features of inverse LP?
|
Red-brown,
discrete papules & flat-topped plaques at flexural areas
|
|
What are the locations of inverse LP?
|
Flexural areas: axillae, inframammary
region, & groin. (antecubital, popliteal, other ectodermal-derived
tissues are rare.)
|
|
What peoples predispose inverse LP?
|
Whites, Asians, & Tunisians
|
|
What are the differences of LP
pigmentosus & inverse LP?
|
LP pigmentosus inversus: flexural areas, no
involvement of sun-exposed areas
LP pigmentosus: flexural areas +
sun-exposed areas.
|
|
Where are the involved areas in those
with palmoplantar LP?
|
1.
Internal plantar arch of feet
2.
Thenar & hypothenar
eminence of hands.
3.
Anterior shin & malleoli
|
|
What are the features of palmoplantar LP?
|
Pruritic, red-purple, scaly plaques (a faint purple hue
& an inflammatory halo) ± callus-like, yellow,
compact keratotic papules/papulonodules on the lateral margins of the fingers
& hand surfaces.
No Wickham striae.
|
|
What are the 4 patterns of palmoplantar
LP?
|
Plaque type, punctate, diffuse
keratoderma, & ulcerated
|
|
What are the differential diagnoses of
palmoplantar LP?
|
Keratotic papules of palms & soles: psoriasis,
warts, calluses, porokeratosis, hyperkeratotic dermatitis, tinea, or
secondary syphilis.
|
|
What are the features of lichenoid drug
eruptions?
|
Localized or generalized with eczematous
papules & plaques with variable degree of desquamation
|
|
What are the cause of lichenoid drug
eruptions?
|
Ingestion
1.
Gold salts
2.
β-blackers
3.
Antimalarials
4.
Diuretics (thiazides,
furosemide, spironolactone)
5.
Penicillamine
6.
Immune checkpoint inhibotors (17%: pembrolizumab, nivolumab,
ipilimumab)
Contact or inhalation of certain
chemicals.
1.
Color film developers
2.
Dental restoration materials
(amalgams: Ag, Hg, Au)
3.
Musk ambrette (合成麝香)
4.
Nickel
5.
Gold
6.
Aminoglycosides
|
|
What are the features of lichenoid drug
eruptions?
|
1.
Often with hyperpigmentation
& alopecia
2.
Rare Wickham striae
3.
Often symmetrical on the
trunk & limbs, less flexural.
|
|
What are the common photo-inducer of LP
or lichenoid drug eruptions?
|
1.
5-FU
2.
Carbamazepine,
chlorpromazine, diazoxide
3.
Ethambutol
4.
Pyritinol (analog of vitamin B₆)
5.
Quinine (antimalaria )
6.
Quinidine (class I antiarrhythmic)
7.
Tetracycline
8.
Thiazide
9.
Furosemide
|
|
Why is lichenoid drug eruption hard to
diagnosed?
|
The latency period varies from months to
>1 year.
|
|
How long is the resolution of lichenoid drug eruption?
|
3-4 months(related to the severity &
extent), but may be years in gold-induced lesions.
|
|
What patients may have genetic
susceptibility of lichenoid drug eruption?
|
Recurrent cases and cases involving
immune-modulating drugs( INF-α, ipilimumab, pembrolizumab, & nivolumab=melanoma-related)
|
|
What are the features of LP-LE?
|
1.
Overlap of LP & LE
(clinical, histology, immunofluorescence)
2.
Red-violet, atrophic patches & plaques + hypopigmentation,
telangiectasia, & minimal scale.(The
bold is the features of LP)
3.
Some individuals→SLE.
4.
Weakly positive ANA.
5.
Prolonged course &
refractory to Tx.
|
|
Where are the locations of LE-LP?
|
The dorsal limbs, esp. hands &
nails(anonychia)
|
|
What are the features of lichen planus
pemphigoides?
|
1.
LP + BP (LP pemphigoides
blisters occur on the lichenoid lesions & normal skin)
2.
Younger age than typical BP
3.
Better prognosis than typical
LP
4.
Can be drug-induced.
|
|
What is the possible pathogenesis of LP
pemphigoides?
|
The brisk LTR→liquefactive
degeneration of keratinocytes→exposure of autoantigens→autoantibody
|
|
What is the antigen of LP pemphigoides?
|
Medical College of Wisconsin domain 4
(MCW-4) of BPAG180
|
|
What are the features of keratosis
lichenoides chronica (Nekam disease)?
|
1.
Lichenoid, keratotic papules
& plaques
2.
A seborrheic distribution,
palms & soles
3.
Folliculo- &
infundibulocentric
4.
Linear or reticulate pattern.
5.
Asymptomatic & refractory
to treatment
6.
A brisk LTR + parakeratosis +
Nφin
the crust
|
|
Lichenoid Graft versus Host Disease
|
|
|
What is the classic acute GVHD?
|
Transplant<100 days, a classic (folliculocentric)
maculopapular rash; GI s/s; &↑bilirubin (liver).
|
|
What is the classic chronic GVHD?
|
Transplant >100 days, dermatitic,
sclerodermoid, or lichenoid eruption
|
|
What is the new classification of GVHD?
|
1.
Acute GVHD: classic, persist,
recurrent, or late-onset (after 100 days)
2.
Classic chronic GVHD, and
overlap syndromes.
|
|
What are the driving cytokine of acute
& chronic GVHD ?
|
Acute: Th2 cytokines
Chronic: Th1/Th17 cytokines (IFN-γ– &
IL-17)
|
|
What are the features of lichenoid GVHD?
|
1.
Classic lichenoid papules
2.
Prominent follicular
involvement of the head & neck & oral involvement.
3.
Onycholysis & cicatricial
alopecia
|
|
What are the differences between GVHD
& LP?
|
Grossly similar, but GVHD has satellite
cell necrosis, plasma cells, & Eφ
|
|
What are the features of lichenoid
keratosis(LK)?
|
A single, nonpruritic, brown to red,
scaling flat-topped plaque on sun-exposed extremities.
|
|
What is the histological feature of LK?
|
LTRs + parakeratosis or a remnant
lentigo, seborrheic keratosis, or actinic keratosis.
|
|
What are the features of lichenoid
dermatitis?
|
Nonclassic LTRs + spongiosis ± granuloma
|
|
What are the differential diagnoses of
lichenoid dermatitis?
|
Dermatitis, drug eruption, lupus erythematosus,
lichen planus, & cutaneous T-cell lymphoma.
|
|
RELATED FINDINGS
|
|
|
What is the most common associations of
LP?
|
Liver diseases: autoimmune chronic active
hepatitis, primary biliary cirrhosis (PBC), & postviral chronic, active
hepatitis.
|
|
What
are the associated autoimmune dzs of LP?
|
SLE,
Sjögren syndrome, dermatomyositis, vitiligo,
&
alopecia areata (Taiwanese data)
|
|
What is the associated infection of oral
LP?
|
HCV in endemic regions (East &
Southeast Asia, South America, the Middle East, & Southern Europe)
|
|
Is there association between cutaneous LP
and HCV?
|
No
|
|
Is there association between LP &
HBV?
|
No
|
|
What is the related HLA of HCV-induced
oral LP?
|
HLA-DR6
|
|
What is the common laboratory abnormality
in LP?
|
1.
Dyslipidemia (higher risk of
cardiac dz & metabolic syndrome)
2.
Hypothyroidism (in 1/3 LPP)
|
|
What is the relationship between LP &
lichen sclerosus et atrophicus?
|
Oral LP→↑lichen sclerosus
et atrophicus
Lichen sclerosus et atrophicus: no risk
of oral LP.
|
|
What is the relationship between LP &
internal malignancies?
|
LP can be a manifestation of paraneoplastic
autoimmune multiorgan syndrome.
|
Hi
ReplyDeleteI just wanted to say thank you!I really appreciate your time effort and information. I am learning so much now.Thanks for sharing such a valuable information it was very helpful
Regards,
Lichen planus pigmentosus specialist
This comment has been removed by the author.
ReplyDeleteThe detailed breakdown of LP pathogenesis is fascinating, especially the link between chronic inflammation and metabolic abnormalities. Since dyslipidemia is a common laboratory finding in these patients, finding a specialized lipid clinic endocrinology is vital for managing the long-term systemic risks associated with this dermatological condition.
ReplyDelete